ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LPCN Lipocine Inc

4.49
0.00 (0.00%)
Pre Market
Last Updated: 04:05:13
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Lipocine Inc LPCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 4.49 04:05:13
Open Price Low Price High Price Close Price Prev Close
4.49
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/07/202417:31EDGAR2Form 8-K - Current report
3/07/202408:00PRNUSLipocine Announces Financial Results for the Full Year Ended..
3/07/202406:08EDGAR2Form 8-K - Current report
3/07/202406:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/06/202408:00PRNUSLipocine to Present at 36th Annual Roth Conference
3/06/202406:01EDGAR2Form 8-K - Current report
2/12/202416:10EDGAR2Form 8-K - Current report
2/06/202408:00PRNUSLipocine Announces Confirmation of Dosing Regimen for..
2/02/202408:00PRNUSLipocine Announces Continued Commercialization of TLANDO®..
1/18/202408:20EDGAR2Form 8-K - Current report
1/18/202408:00PRNUSLipocine and Verity Pharma Enter into License Agreement for..
12/19/202310:00EDGAR2Form 8-K - Current report
12/19/202308:00PRNUSLipocine to Present at Biotech Showcase 2024
11/22/202316:15EDGAR2Form S-3 - Registration statement under Securities Act of..
11/13/202314:45EDGAR2Form 8-K - Current report
11/13/202314:45PRNUSLipocine Releases Late Breaking Presentation on LPCN 1148..
11/08/202313:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202309:50EDGAR2Form 8-K - Current report
11/08/202308:00PRNUSLipocine Announces Financial Results for the Third Quarter..
11/01/202309:31EDGAR2Form 8-K - Current report
11/01/202308:00PRNUSLipocine to Present Clinical Data on LPCN 1148 at The Liver..
10/26/202309:35EDGAR2Form 8-K - Current report
10/26/202308:00PRNUSLipocine Completes Successful Meeting with FDA on LPCN 1154..
10/23/202319:00PRNUSLipocine to Present at the H.C. Wainwright Annual NASH..
10/06/202316:05EDGAR2Form 8-K - Current report
9/19/202316:10EDGAR2Form 8-K - Current report
9/19/202316:05PRNUSLipocine to Present at the Cantor Fitzgerald Global..
8/10/202308:35EDGAR2Form 8-K - Current report
8/10/202308:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202308:00PRNUSLipocine Announces Financial Results for the Second Quarter..
7/27/202306:45EDGAR2Form 8-K - Current report
7/27/202306:30PRNUSLPCN 1148 Phase 2 Study Meets Primary Endpoint in Patients..
6/14/202308:00PRNUSLipocine to Present at H.C. Wainwright Annual..
6/07/202308:00PRNUSLipocine to Present LPCN 1148 and LPCN 1144 at the EASL..
5/16/202307:00PRNUSPositive Topline Clinical Results Support Streamlined..
5/11/202306:00PRNUSLipocine Announces Financial Results for the First Quarter..
4/03/202308:00PRNUSFirst Subject Dosed in the Clinical Bridge Study with..

Your Recent History

Delayed Upgrade Clock